Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.
D000328:Adult; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009496:Neurotensin / Q000134:cerebrospinal fluid*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D012560:Schizophrenia, Catatonic / Q000134:cerebrospinal fluid / Q000188:drug therapy; D012562:Schizophrenia, Disorganized / Q000134:cerebrospinal fluid / Q000188:drug therapy; D012563:Schizophrenia, Paranoid / Q000134:cerebrospinal fluid / Q000188:drug therapy; D012565:Schizophrenic Psychology; D013268:Stimulation, Chemical
D014150:Antipsychotic Agents; D009496:Neurotensin